http://www.evelobio.com
Evelo Biosciences, Inc. Company Intro
Evelo is pioneering therapies that modulate systemic immune response by acting on the gut-body network - monoclonal microbials. They have the potential to treat many diseases, including inflammatory disease, cancer, autoimmune disease, metabolic, neurobehavior and neuroinflammatory diseases.
Industry
Healthcare
Evelo Biosciences, Inc. Headquaters
620 Memorial Drive
Cambridge,02139
United States
Evelo Biosciences, Inc. Share price
17 May 2023 13:09 GMT
$0.1519
0.01 (7.27 %)
Evelo Biosciences, Inc. Market cap
$15.73 M
WMC RANKING
2024
Evelo Biosciences, Inc. # 471
BiotechnologyLatest Evelo Biosciences, Inc. News
12 Feb 2024
Reviewing China Health Industries (OTCMKTS:CHHE) & Evelo Biosciences (NASDAQ:EVLO)
Read Reviewing China Health Industries (OTCMKTS:CHHE) & Evelo Biosciences (NASDAQ:EVLO) at Defense World.
10 Feb 2024
Biopharma Layoff Tracker 2024: Roche, Sandoz, Synlogic and More Cut Staff
Follow along as BioSpace keeps you up-to-date on the latest pharma and biotech layoffs.
10 Feb 2024
Biopharma Layoff Tracker 2024: Roche, Sandoz, Synlogic and More Cut Staff
Follow along as BioSpace keeps you up-to-date on the latest pharma and biotech layoffs.
WMC Market Score
WMC Market to Revenue Score
Evelo Biosciences, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Evelo Biosciences, Inc. | USD | $0 | $96,096 | $-98,821 | $157M | 471 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Evelo Biosciences, Inc. Social Followers vs Top 4 Industry Competitors
Evelo Biosciences, Inc. Post vs Top 4 Industry Competitors
Evelo Biosciences, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Evelo Biosciences, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Evelo Biosciences, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Evelo Biosciences, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
